{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:20:09Z","timestamp":1784593209711,"version":"3.55.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brainanddevelopment.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.braindev.2021.04.010","type":"journal-article","created":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T00:49:05Z","timestamp":1621385345000},"page":"851-856","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Effective treatments for FGF12-related early-onset epileptic encephalopathies patients"],"prefix":"10.1016","volume":"43","author":[{"given":"Qi","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjun","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2021.04.010_b0005","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1212\/WNL.0000000000002752","article-title":"Gain-of-function FHF1 mutation causes early-onset epileptic encephalopathy with cerebellar atrophy","volume":"86","author":"Siekierska","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2021.04.010_b0010","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000133","article-title":"Phenytoin-responsive epileptic encephalopathy with a tandem duplication involving FGF12","volume":"3","author":"Shi","year":"2017","journal-title":"Neurol Genet"},{"key":"10.1016\/j.braindev.2021.04.010_b0015","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/cge.13592","article-title":"FGF12p.Gly112Ser variant as a cause of phenytoin\/phenobarbital responsive epilepsy","volume":"96","author":"Paprocka","year":"2019","journal-title":"Clin Genet"},{"key":"10.1016\/j.braindev.2021.04.010_b0020","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1212\/NXG.0000000000000115","article-title":"FHF1 (FGF12) epileptic encephalopathy","volume":"2","author":"Al-Mehmadi","year":"2016","journal-title":"Neurol Genet"},{"key":"10.1016\/j.braindev.2021.04.010_b0025","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000120","article-title":"De novo FGF12 mutation in 2 patients with neonatal-onset epilepsy","volume":"2","author":"Guella","year":"2016","journal-title":"Neurol Genet"},{"key":"10.1016\/j.braindev.2021.04.010_b0030","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ejpn.2017.04.001","article-title":"Heterogeneity of FHF1 related phenotype: Novel case with early onset severe attacks of apnea, partial mitochondrial respiratory chain complex II deficiency, neonatal onset seizures without neurodegeneration","volume":"21","author":"Villeneuve","year":"2017","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.braindev.2021.04.010_b0035","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.braindev.2018.04.002","article-title":"Two Japanese cases of epileptic encephalopathy associated with an FGF12 mutation","volume":"40","author":"Takeguchi","year":"2018","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2021.04.010_b0040","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/epi.14698","article-title":"The Epilepsy Genetics Initiative: Systematic reanalysis of diagnostic exomes increases yield","volume":"60","author":"Epilepsy Genetics Initiative","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2021.04.010_b0045","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1600-0404.1983.tb01535.x","article-title":"Side effects of phenobarbital and phenytoin during long-term treatment of epilepsy","volume":"97","author":"Iivanainen","year":"1983","journal-title":"Acta Neurol Scand Suppl"},{"key":"10.1016\/j.braindev.2021.04.010_b0050","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1046\/j.1528-1157.2001.10401.x","article-title":"International League Against E. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology","volume":"42","author":"Engel","year":"2001","journal-title":"Epilepsia"},{"issue":"Suppl 1","key":"10.1016\/j.braindev.2021.04.010_b0055","first-page":"24","article-title":"Phenytoin: effective but insidious therapy for epilepsy in people with intellectual disability","volume":"42","author":"Iivanainen","year":"1998","journal-title":"J Intellect Disabil Res"},{"key":"10.1016\/j.braindev.2021.04.010_b0060","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1684\/epd.2011.0444","article-title":"Side effects of phenobarbital in epilepsy: a systematic review","volume":"13","author":"Zhang","year":"2011","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.braindev.2021.04.010_b0065","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1046\/j.1528-1157.2001.18800.x","article-title":"Topiramate rapidly raises brain GABA in epilepsy patients","volume":"42","author":"Petroff","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2021.04.010_b0070","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1111\/j.1528-1157.2000.tb00111.x","article-title":"Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed","volume":"41","author":"Deckers","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2021.04.010_b0075","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.3390\/ph3082362","article-title":"Rational Polytherapy with Antiepileptic Drugs","volume":"3","author":"Lee","year":"2010","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.braindev.2021.04.010_b0080","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1517\/17425250802677826","article-title":"Pharmacodynamic interactions between antiepileptic drugs: preclinical data based on isobolography","volume":"5","author":"Czuczwar","year":"2009","journal-title":"Expert Opin Drug Metab Toxicol"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760421000887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760421000887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:49:29Z","timestamp":1759952969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760421000887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":16,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0387760421000887"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2021.04.010","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effective treatments for FGF12-related early-onset epileptic encephalopathies patients","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2021.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}